• Nie Znaleziono Wyników

Treatment of saddle pulmonary embolism with streptokinase in an 83 year-old man - a case report

N/A
N/A
Protected

Academic year: 2022

Share "Treatment of saddle pulmonary embolism with streptokinase in an 83 year-old man - a case report"

Copied!
2
0
0

Pełen tekst

(1)

www.kardiologiapolska.pl

Chorzy trudni typowi/Case report Kardiologia Polska

2011; 69, 1: 56–57 ISSN 0022–9032

Address for correspondence:

Address for correspondence:

Address for correspondence:

Address for correspondence:

Address for correspondence:

Gonenc Kocabay, MD, Kosuyolu Heart and Research Hospital, 34846 Cevizli, Istanbul, Turkey, e-mail: gonenckocabay@yahoo.com Received:

Received:

Received:

Received:

Received: 15.03.2010 Accepted:Accepted:Accepted:Accepted:Accepted: 23.03.2010 Copyright © Polskie Towarzystwo Kardiologiczne

Treatment of saddle pulmonary embolism with streptokinase in an 83 year−old man

— a case report

Leczenie zatoru typu „jeździec” tętnicy płucnej za pomocą streptokinazy u 83-letniego chorego — opis przypadku

Can Yucel Karabay, Gonenc Kocabay, Oguz Karaca, Cevat Kirma

Kosuyolu Heart and Research Hospital, Istanbul, Turkey

A b s t r a c t

Saddle pulmonary embolism (PE) is an embolus at the level of the bifurcation of the pulmonary trunk that extends into both main pulmonary arteries. Because of the unstable, large clot burden in the pulmonary artery and the risk of sudden haemo- dynamic collapse and sudden death, identifying a saddle embolus is extremely important. In this report, we describe success- ful treatment with streptokinase of a saddle PE in an elderly patient.

Key words: saddle pulmonary embolism, elderly patient, streptokinase

Kardiol Pol 2011; 69, 1: 56–57

INTRODUCTION

Saddle pulmonary embolism (PE) is an embolus at the level of the bifurcation of the pulmonary trunk that extends into both main pulmonary arteries. Because of the unstable, large clot burden in the pulmonary artery and the risk of sudden haemodynamic collapse and sudden death, identifying a sad- dle embolus is extremely important [1, 2]. In this report, we describe a successful treatment with streptokinase of a sad- dle PE in an elderly patient.

CASE REPORT

An 83 year-old man with a medical history of chronic ob- structive pulmonary disease was admitted to our hospital because of sudden-onset dyspnea and chest pain. Physical examination revealed that he was dyspneic and tachypneic (respiratory rate was 25/min). His blood pressure was 90/

/50 mm Hg, and his heart rate was regular at 120 beats/min.

He had jugular venous distention. On auscultation, there was 2/6 systolic murmur on the tricuspid area. He had coarse and prolonged breath sounds bilaterally. The electrocardiogram demonstrated sinus tachycardia. An arterial blood gas mea-

surement obtained on room air showed severe hypoxic hy- pocapnia with respiratory alkalosis. For low partial pressure of oxygen, he was started on low dose oxygen with venturi mask. Transthoracic echocardiography (TTE) revealed a large echogenic mass consisting of an embolus in the main pul- monary artery extending into the left and right pulmonary arteries (Fig. 1). The right ventricle was enlarged with flat- tened interventricular septum, indicating right ventricular pressure overload. Doppler examination showed mode- rate tricuspid regurgitation and pulmonary artery systolic pres- sure of 70 mm Hg. On Doppler ultrasound, the patient had venous thrombosis in his right femoral and popliteal veins.

Because of the location and size of the thrombi and the patient’s clinical status, we decided to initiate urgent throm- bolytic therapy. We preferred streptokinase (250,000 IU in- travenously over 30 min, then 100,000 IU/h for 24 h) for the treatment. Unfractionated heparin infusion was instituted af- ter thrombolytic administration.

At the end of the thrombolytic therapy, the saddle em- bolus was completely resolved on TTE (Fig. 2), with a clinical and haemodynamic improvement. His blood pressure was

(2)

www.kardiologiapolska.pl

57 Treatment of saddle pulmonary embolism with streptokinase in an 83 year-old man

Figure 2.

Figure 2.

Figure 2.

Figure 2.

Figure 2. Transthoracic echocardiogram showing the main pulmonary artery without saddle embolus; abbreviations as in Figure 1

Figure 1.

Figure 1.

Figure 1.

Figure 1.

Figure 1. A saddle embolus (white arrow) at the bifurcation of the main pulmonary artery on transthoracic echocardiogram;

MPA — main pulmonary artery; LPA — left pulmonary artery;

RPA — right pulmonary artery; Ao — aorta

DISCUSSION

Saddle PE represents a large and unstable clot load. The clini- cal presentation of saddle PE varies from the absence of symp- toms to death. Ryu et al. [2] reported that the frequency of saddle PE is 2.6%.

It has been suggested that saddle PE should be urgent- ly surgically treated. However, some authors have report- ed successful recovery using thrombolysis or even antico- agulation [3]. A few studies have found that saddle embo- lism does not indicate unfavourable clinical outcomes or in-hospital mortality rates [2–4]. However, in these reports, the patients did not have high risk such as shock, syncope or heart failure.

Although thrombolytic therapy is generally avoided in elderly patients, there are a few case reports in the litera- ture [5]. We initiated thrombolytic therapy to our elderly unstable patient after a diagnosis of saddle PE by using TTE.

Because of the lack of a randomised control trial, the deci- sion to use a thrombolytic agent needs to be made on a case-by-case basis. Risk factors for haemorrhage should be not overlooked.

Other methods such as contrast enhanced spiral com- puted tomography, ventilation perfusion scanning and stan- dard angiography can be used to diagnose PE. The TTE is an attractive method because it is noninvasive and does not require an unstable patient to be transported. Echocar- diography should not only be used for diagnosis, it is also useful for risk stratification and monitoring the effects of treatment.

References

1. Cooper JM, Beckman JA. Massive pulmonary embolism:

a remarkable case and review of treatment. Vasc Med, 2002; 7:

181–185.

2. Ryu JH, Pellikka PA, Froehling DA et al. Saddle pulmonary embolism diagnosed by CT angiography: frequency, clinical features and outcome. Respir Med, 2007; 101: 1537–1542.

3. Pruszczyk P, Pacho R, Ciurzynski M et al. Short term clinical outcome of acute saddle pulmonary embolism. Heart, 2003;

89: 335–336.

4. Kaczyńska A, Pacho R, Bochowicz A et al. Does saddle embo- lism influence short-term prognosis in patients with acute pul- monary embolism? Kardiol Pol, 2005; 62: 119–127.

5. Lora-Tamayo J, Gasch O, Riera-Mestre A et al. Thrombolysis in elderly patients with massive pulmonary embolism. J Am Geriatr Soc, 2008; 56: 1964–1966.

120/70 mm Hg, and heart rate was 86 beats/min. Pulmonary artery systolic pressure had decreased to 40 mm Hg. He was discharged from hospital on the sixth day of hospitalisation with oral warfarin therapy.

Cytaty

Powiązane dokumenty

This case report may encourage further, prospective studies in the hope to define whether and when chest ultrasound might find its place in the diagnostic strategy of PE, especially

niem dla D-dimerów w ŻChZZ jest ich przydatność w określaniu ryzyka nawrotu choroby po odstawie- niu leczenia przeciwzakrzepowego — prawidłowe stężenie D-dimerów

Exciting evidence has been made in recent years in genetic studies of CAD and myocardial infarction (MI). One disease- -causing gene for CAD and MI has been identified as MEF2A,

Pulmonary CT angiography revealed pulmonary embolism in the form of numerous defects in the contrast fillings of the pulmonary arteries: on the right side – in the

Jednak w dramatycznych przypadkach zatorowości płucnej przebiegających ze wstrząsem może być konieczne podanie leczenia trombolitycznego.. Po porodzie w leczeniu

Mimo istotnego postępu, obserwowanego w os- tatnich latach, w leczeniu chorób onkohematolo- gicznych kluczowym lekiem w leczeniu nadpłytko- wości samoistnej (ET,

Co prawda w przypadku opisanej pacjentki w dniu przyjęcia rozpoznano zatorowość płucną niewysokiego ryzyka, jednak w badaniu angio-TK była to zatorowość płucna obwodowa,

Naturalne i rekombinowane pre- paraty IFN-a stosuje się w leczeniu przewlekłych wirusowych zapaleń wątroby (CH) i terapii wspomagającej niektórych chorób rozrostowych